Gunderson Dettmer represented client Crescendo Health, a digital health company, in its $3.4 million Seed financing led by Define Ventures. Crescendo’s healthcare platform is intended to transform the way patient health data is collected and used to advance clinical trial research. The new capital will be used to advance software tools used for research and tracking treatment outcomes.

In the announcement of the transaction, Co-founder and CEO of Crescendo Health Sam Roosz said, “Using the traditional tools of research, patients come to study sites where researchers capture as much information as possible. But, the missing piece is what’s happening beyond the study sites. What they don’t have are the insights into the care a patient is receiving at their various providers. For too long, this dynamic has plagued researchers and has been baked into the expectations of how clinical trials are conducted. So, at the highest level, we’re providing a path for researchers to hybridize the best of both worlds by getting that data.”

The Gunderson Dettmer deal team was led by Cody Peterson and included Bess Benhamou.

Companies
Crescendo Health
Define Ventures